Skip to content

Effects of Combined EEG and Cerebral Oxygen Saturation Monitoring on Postoperative Cognition in Weakened Patients Under General Anesthesia

Effects of Combined EEG and Cerebral Oxygen Saturation Monitoring on Postoperative Cognition in Weakened Patients Under General Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117852
Enrollment
Unknown
Registered
2026-01-29
Start date
2026-01-30
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction

Interventions

Experimental group (medication adjustment group using EEG and cerebral oxygen saturation monitoring).:The depth of sedation and analgesia was monitored using the HXD-I deep anesthesia monitoring instr
Control group (medication management group based solely on the anesthesia physician's experience, without adjusting according to EEG and cerebral oxygen saturation monitoring).:The medication was not

Sponsors

The Affiliated Sheng Jing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients undergoing elective bowel resection surgery under general anesthesia at Shengjing Hospital of China Medical University from March 2025 to March 2026. 2.Patients with a preoperative Groningen Frailty Index (GFI) score of >=3, indicating frailty. 3.ASA classification: Class II-III. 4.Patients who voluntarily participate and sign informed consent after fully understanding the purpose, procedures, risks, and benefits of this study and discussing them with others.

Exclusion criteria

Exclusion criteria: 1. It was diagnosed as having cognitive impairment before the surgery. 2. It is expected that the patient will not be able to continue the treatment after the surgery. 3. The total hospital stay is less than three days. 4. Before the surgery, the patient had hearing or vision impairments, restricted use of the dominant hand, etc. (unable to complete the screening scale). 5. In the past 1 month, the patient has used drugs that may affect cognitive function or anesthesia effect (such as antidepressants, sedative-hypnotics, etc.). 6. The patient has a history of mental illness (such as depression, anxiety disorder, etc.). 7. The patient or the patient's family refuses to participate in the trial.

Design outcomes

Primary

MeasureTime frame
The incidence of cognitive dysfunction on postoperative day 1 (D1) and postoperative day 3 (D2) in both groups.;

Secondary

MeasureTime frame
The incidence of cognitive dysfunction at postoperative 2 weeks and postoperative 1 month.;Richmond Agitation-Sedation Scale (RASS);Cerebral oxygen saturation (rSO2);Nine-Hole Peg Test scores before and after surgery;Postoperative hospital stay (days);Wavelet Index (WLi);Intraoperative medication dosage;The incidence of other anesthesia-related complications postoperatively (such as severe nausea and vomiting, dizziness, headache, etc.);Pain Threshold Index (PTi);

Countries

China

Contacts

Public ContactBo Long

The Affiliated Sheng Jing Hospital of China Medical University

longb@sj-hospital.org+86 24 9661 5682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026